https://en.bioecon.ru/companies/agilent/Recent content in Agilent on BioeconHugoen-USMon, 27 Jul 2026 10:55:47 +0700https://en.bioecon.ru/technology/companion-diagnostics-platforms/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/companion-diagnostics-platforms/Tissue-based immunohistochemistry (IHC) and FISH platforms that determine whether a specific patient is eligible for a specific targeted therapy, sold and regulated as a companion diagnostic (CDx) tied directly to a drug label — distinct from blood-based liquid-biopsy CDx: Ventana/Roche Tissue Diagnostics, Agilent Dako and Myriad Genetics in the US, 3D Medicines in China, and MedGenome in India.https://en.bioecon.ru/technology/breathomics/Thu, 25 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/breathomics/Non-invasive breath analysis using VOC patterns for early diagnosis and continuous disease monitoring.https://en.bioecon.ru/technology/lab-automation-liquid-handling/Wed, 24 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/lab-automation-liquid-handling/High-throughput robotic liquid handling systems and integrated laboratory automation platforms that exponentially increase assay throughput, eliminate human error, and enable next-generation genomics and synthetic biology.